Versameb is developing a new technology platform for local protein delivery through mRNA induction in multiple disease areas, focusing first on regenerative medicine.

Products, services, technology

VERSAMEB's platform has produced candidates that are at an advanced preclinical stage.

Cooperation possibilities

Versameb is willing to exploit the potential of its proprietary platform with renowned pharmaceutical and biotech companies.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2017
  • Number of employees in Switzerland
    1-9
Key business